Open AccessAbstract 3900: STAT3 inhibition with Galiellalactone effectively targets the prostate cancer stem-like cell population
Author(s) -
Giacomo Canesin,
Anne T. Collins,
Rebecka Hellsten,
Norman J. Maitland,
Anders Bjartell
Publication year - 2017
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2017-3900
Subject(s) - du145 , cancer stem cell , cd44 , cancer research , prostate cancer , population , clonogenic assay , side population , stem cell , stat3 , biology , cancer , cell , medicine , lncap , microbiology and biotechnology , signal transduction , genetics , environmental health